0001035354 2026-06-01 2026-06-01 0001035354 1 2026-06-01 2026-06-01 0001035354 2 2026-06-01 2026-06-01 0001035354 3 2026-06-01 2026-06-01 iso4217:USD pure S-1 S-1/A EX-FILING FEES 333-295651 0001035354 Eloxx Pharmaceuticals, Inc. N/A N/A S-1 Eloxx Pharmaceuticals, Inc. false Equity Common Stock, par value $0.01 per share true 10500000.00 0.0001381 1450.05 false Equity Pre-Funded Warrants to purchase Common Stock true 0.0001381 0.00 true Equity Common Stock, par value $0.01 per share true 50000000.00 6905.00 60500000.00 8355.05 6905.00 0.00 1450.05 The Maximum Aggregate Offering Price is estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Represents the sum of the pre-funded warrant offering price of $10.99 per warrant and the exercise price of $0.01 per share issuable pursuant to the pre-funded warrants. In accordance with SEC guidance and Rule 457(i), the entire fee is allocated to the common stock, and no separate fee is recorded for the pre-funded warrants. The Registrant previously paid a registration fee of $6,905.00 in connection with initial filing of the Registration Statement on Form S-1 on May 7, 2026.